dipyridamole 200mg/5ml oral suspension
syri pharma limited t/a thame laboratories - dipyridamole - oral suspension - 200 mg/5 millilitre(s) - platelet aggregation inhibitors excl. heparin; dipyridamole
aspirin and dipyridamole- aspirin and dipyridamole capsule, extended release
teva pharmaceuticals usa, inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps. aspirin may cause severe urticaria, angioedema or bronchospasm. do not use aspirin in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects , pregnancy category d. [see warnings and precautions (5.4) ]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pregnancy [se
aspirin and extended-release dipyridamole- aspirin and extended-release dipyridamole capsule
american health packaging - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), dipyridamole (unii: 64alc7f90c) (dipyridamole - unii:64alc7f90c) - aspirin 25 mg - aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. aspirin and extended-release dipyridamole capsules are contraindicated in patients with known hypersensitivity to any of the product components. aspirin, usp is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (nsaid) products and in patients with the syndrome of asthma, rhinitis and nasal polyps. aspirin, usp may cause severe urticaria, angioedema or bronchospasm. do not use aspirin, usp in children or teenagers with viral infections because of the risk of reye syndrome. teratogenic effects, pregnancy category d. [see warnings and precautions (5.4)]. aspirin can result in excessive blood loss at delivery as well as prolonged gestation and prolonged labor. because of these effects on the mother and because of adverse fetal effects seen with aspirin during the later stages of pr
dipyridamole 50mg/5ml oral suspension sugar free
rosemont pharmaceuticals ltd - dipyridamole - oral suspension - 10mg/1ml
dipyridamole 50mg/5ml oral suspension sugar free
pinewood healthcare - dipyridamole - oral suspension - 10mg/1ml
dipyridamole 25mg tablets
sigma pharmaceuticals plc - dipyridamole - oral tablet - 25mg
dipyridamole 100mg tablets
a a h pharmaceuticals ltd - dipyridamole - oral tablet - 100mg
dipyridamole 100mg tablets
accord-uk ltd - dipyridamole - oral tablet - 100mg
dipyridamole 100mg tablets
viatris uk healthcare ltd - dipyridamole - oral tablet - 100mg
dipyridamole 100mg tablets
kent pharma (uk) ltd - dipyridamole - oral tablet - 100mg